Spry Therapeutics
Spry Therapeutics is a startup headquartered in Mumbai, India, founded in 2021. It has raised at least $15.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Spry Therapeutics has raised at least $15.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Spry Therapeutics sits inside the Pune and Mumbai R&D ecosystem in the Global R&D Labs Directory.
Related
- Innovation profile of Mumbai
- India: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Spry Therapeutics do?
Spry Therapeutics is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has Spry Therapeutics raised?
At least $15.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Spry Therapeutics based?
Spry Therapeutics is headquartered in Mumbai, India.
When was Spry Therapeutics founded?
Spry Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.